Latest News about BNTX
Recent news which mentions BNTX
Will Investors Notice Exciting Sign On BioNTech's Chart?
December 19, 2022
Tickers
BNTX
From Benzinga
The 7 Hottest Healthcare Stocks to Own for 2023 and Beyond
December 18, 2022
From InvestorPlace
BioNTech upgraded to buy on high hopes for combined flu/COVID vaccine and oncology pipeline
December 15, 2022
From MarketWatch
BioNTech Stock Gets Upgrade, Analyst Sees Multiple Upside Opportunities
December 15, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2022
December 15, 2022
From Benzinga
Why Is Novavax (NVAX) Stock Plunging Today?
December 15, 2022
From InvestorPlace
Pfizer Expects $10-$15B From mRNA Vaccine Sales By 2030, Sees $17B Revenues Lost Due To Patent Expiry
December 13, 2022
From Benzinga
COVID cases continue upward march as new, more infectious variants emerge and flu, RSV and other respiratory illnesses spread
December 12, 2022
From MarketWatch
Omicron subvariants are now dominant in the U.S. as COVID cases tick up and New York City becomes a hot spot
December 09, 2022
From MarketWatch
FDA Authorizes Pfizer/BioNTech And Moderna's Bivalent COVID Shots For 6 Months Old
December 08, 2022
From Benzinga
US Supports Delay On COVID Patent Waiver Extension Decision
December 06, 2022
From Benzinga
From Benzinga
From Benzinga
China begins to loosen COVID rules
December 05, 2022
From MarketWatch
BioNTech, Vertex Pharmaceuticals And Other Big Biotechnology Stocks From Benzinga's Most Accurate Analysts
December 02, 2022
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
December 01, 2022
From Benzinga
BioNTech, Ryvu Therapeutics Join Forces For Immuno-Modulatory Candidates
November 30, 2022
Tickers
BNTX
From Benzinga
Quant Ratings Updated on 59 Stocks
November 29, 2022
From InvestorPlace
IMF head joins chorus calling on China to adapt COVID strategy as officials pledge to boost vaccinations among elderly
November 29, 2022
From MarketWatch
China’s zero-COVID strategy makes no sense and its homegrown vaccines are not ‘particularly effective,’ says Fauci
November 28, 2022
From MarketWatch
2 Biotech Stocks You Can Buy and Hold for the Next Decade
November 28, 2022
From Motley Fool
Is Novavax Stock a Buy Now?
November 26, 2022
From Motley Fool
From Benzinga
Researchers Working On Universal mRNA-Influenza Vaccine Aiming For Baseline Immune Memory For Diverse Strains
November 25, 2022
From Benzinga
Is Now the Time for Income Investors to Buy This Big Pharma Stock?
November 24, 2022
From Motley Fool
7 Stocks on the Perfect 10 List
November 23, 2022
Tags
Stocks to Buy
VIST
NYSE:ALB,NASDAQ:BNTX,NASDAQ:INMD,NASDAQ:MRNA,NYSE:SQM,NASDAQ:VRTX,NYSE:VIST,NYSE:MRK
From InvestorPlace
PFE Stock Could Be the Booster Shot Your Portfolio Needs Now
November 23, 2022
From InvestorPlace
Jim Cramer Says China's Vaccines 'Don't Work' But Xi Won't Admit It
November 22, 2022
From Benzinga
Confused about COVID boosters? Here’s what the science and the experts say about the new generation of shots.
November 22, 2022
From MarketWatch
2 Reasons to Buy Pfizer and 1 Reason to Sell
November 20, 2022
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.